TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23947902

Group type: EXPERIMENTAL
Intervention: Silicon nitride ceramic cages
Number of subjects: 100

Group type: COMPARATOR
Intervention: PEEK cages
Number of subjects: 100
Study: 19823907

Group type: EXPERIMENTAL
Intervention: Training on a virtual laparoscopic simulator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17917696

Group type: EXPERIMENTAL
Intervention: Creatine (20 g x d(‐1))
Number of subjects: 11

Group type: COMPARATOR
Intervention: Carbohydrate (20 g x d(‐1))
Number of subjects: 11
Study: 16025961

Group type: EXPERIMENTAL
Intervention: Quyu Xiaoban capsule (QXC)
Number of subjects: 80
Study: 14708338

Group type: EXPERIMENTAL
Intervention: Composite outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single primary outcome
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All-cause mortality
Number of subjects: 0
Study: 10399048

Group type: EXPERIMENTAL
Intervention: Peroral methadone
Number of subjects: 134

Group type: COMPARATOR
Intervention: Injectable methadone
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Awareness of health risks
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Reasons for injection
Number of subjects: 134
Study: 8559353

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plasma exchange (PLEX)
Number of subjects: 50
Study: 1814297

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 42
Study: 7049190

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 310

Group type: COMPARATOR
Intervention: Gefarnate
Number of subjects: 310
Study: 30217554

Group type: EXPERIMENTAL
Intervention: Intrapartum midwifery care
Number of subjects: 209
Study: 30477474

Group type: EXPERIMENTAL
Intervention: Immediate adaptations (no wait)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual adaptations (3-4 month wait)
Number of subjects: 60
Study: 26865133

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% 20 ml
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ropivacaine 0.75% 5 ml
Number of subjects: 30
Study: 24144551

Group type: EXPERIMENTAL
Intervention: Orthokeratology (ortho-k)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Single vision lenses (SVLs)
Number of subjects: 2
Study: 22108393

Group type: EXPERIMENTAL
Intervention: Inhalation anesthesia
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Intravenous anesthesia
Number of subjects: 2000
Study: 19264567

Group type: EXPERIMENTAL
Intervention: Mechanical and/or pharmacological prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study: 17125997

Group type: EXPERIMENTAL
Intervention: 300 microg of intrathecal diamorphine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: intrathecal diamorphine (100 microg, 200 microg, or 300 microg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: intrathecal diamorphine
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study: 15970816

Group type: EXPERIMENTAL
Intervention: Monitoring + fetal pulse oximetry
Number of subjects: 360

Group type: COMPARATOR
Intervention: Monitoring alone
Number of subjects: 360
Study: 11923550

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9706852

Group type: EXPERIMENTAL
Intervention: Interdental brushes (IDB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dental floss (DF)
Number of subjects: 26
Study: 7636515

Group type: EXPERIMENTAL
Intervention: Postpartum interview data
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Obstetric records
Number of subjects: 367
Study: 2244769

Group type: EXPERIMENTAL
Intervention: Health promotion clinic model
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Physician-oriented model
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Patient education model
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1224
Study: 283002

Group type: EXPERIMENTAL
Intervention: Toothpaste A (active ingredient)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Toothpaste B (active ingredient)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 60
Study: 30802558

Group type: EXPERIMENTAL
Intervention: Trifarotene 50 μg/g cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 28662074

Group type: EXPERIMENTAL
Intervention: Brown rice diet
Number of subjects: 28

Group type: COMPARATOR
Intervention: White rice diet
Number of subjects: 28
Study: 26388539

Group type: EXPERIMENTAL
Intervention: Integrated Cognitive Behavioral Therapy (ICBT) plus Standard Care (SC)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Individual Addiction Counseling (IAC) plus Standard Care (SC)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Standard Care (SC) alone
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Medication Assisted Treatment (MAT)
Number of subjects: 126
Study: 23824248

Group type: EXPERIMENTAL
Intervention: 5‐HT2A receptor blockade with ketanserin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control session (no ketanserin)
Number of subjects: 0
Study: 21307305

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serum salicylate levels
Number of subjects: 0
Study: 18848957

Group type: EXPERIMENTAL
Intervention: Cocaine alone (0.2 mg/kg, IV)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cocaine (0.2 mg/kg, IV) + Nalbuphine (5 mg/70 kg, IV)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Cocaine alone
Number of subjects: 7
Study: 18048942

Group type: EXPERIMENTAL
Intervention: Vibration group
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Exercise-without-vibration group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 16298773

Group type: EXPERIMENTAL
Intervention: 1.8 mg sustained-release melatonin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 11803097

Group type: EXPERIMENTAL
Intervention: Closure of peritoneum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonclosure of peritoneum
Number of subjects: 60
Study: 10992868

Group type: EXPERIMENTAL
Intervention: Modified drug delivery system (study group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing drug delivery system (control group)
Number of subjects: 0
Study: 7662481

Group type: EXPERIMENTAL
Intervention: Lidocaine (20 ml of 1% lidocaine)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Pethidine/diazepam (intravenous)
Number of subjects: 52
Study: 2526706

Group type: EXPERIMENTAL
Intervention: 10 mg flunarizine for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 0
Study: 825134

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) small particles
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) intermediate particles
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) large particles
Number of subjects: 5
Study: 31033637

Group type: EXPERIMENTAL
Intervention: 12-week exercise intervention
Number of subjects: 344
Study: 27012857

Group type: EXPERIMENTAL
Intervention: Empathy prime (line drawing depicting two individuals pointing in the same direction)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-empathy prime (line drawing depicting two individuals pointing in opposite directions)
Number of subjects: 60
Study: 26121746

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg daily taken orally for 1 week)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 24171699

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise followed by prescription of physical activity
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with a behavioural approach followed by prescription of physical activity
Number of subjects: 216

Group type: COMPARATOR
Intervention: Prescription of physical activity alone without neck-specific exercises
Number of subjects: 216
Study: 21424150

Group type: EXPERIMENTAL
Intervention: Stapled gastroduodenostomy
Number of subjects: 197

Group type: COMPARATOR
Intervention: Handsewn gastroduodenostomy
Number of subjects: 197
Study: 18498882

Group type: EXPERIMENTAL
Intervention: Ibuprofen tablets
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ibuprofen liquigels
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Obturation
Number of subjects: 39
Study: 16837545

Group type: EXPERIMENTAL
Intervention: Conjunctival autograft
Number of subjects: 287

Group type: COMPARATOR
Intervention: Amniotic membrane transplantation
Number of subjects: 287
Study: 12851622

Group type: EXPERIMENTAL
Intervention: Micro stent II (M)
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Sito (S)
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Pura Vario (PV)
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Inflow (ID)
Number of subjects: 925

Group type: COMPARATOR
Intervention: Early adverse events (all stent types)
Number of subjects: 925
Study: 10822392

Group type: EXPERIMENTAL
Intervention: Heat exposure at 33 degrees C and 50-55% relative humidity for 1 hour
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ambient temperature of 25 degrees C and 50% relative humidity for 1 hour (baseline)
Number of subjects: 14
Study: 8777252

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy including cisplatin; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Local treatment alone; specific details not mentioned.
Number of subjects: 0
Study: 1795048

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MR)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Computerised Tomography (CT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both CT and MR
Number of subjects: 15
Study: 6134542

Group type: EXPERIMENTAL
Intervention: Ro 15-1788
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ro 15-1788 with flunitrazepam
Number of subjects: 0
Study: 31061043

Group type: EXPERIMENTAL
Intervention: Retrograde intramedullary nail
Number of subjects: 82

Group type: COMPARATOR
Intervention: Anatomical locking plate
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 82
Study: 29797910

Group type: EXPERIMENTAL
Intervention: Modified bilateral acupuncture
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Modified unilateral acupuncture
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Routine bilateral acupuncture
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine unilateral acupuncture
Number of subjects: 160
Study: 27467458

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 128

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 128
Study: 24170099

Group type: EXPERIMENTAL
Intervention: 12 or 24 mg iv alemtuzumab
Number of subjects: 334

Group type: COMPARATOR
Intervention: 44 μg sc interferon‐β‐1a (SC IFNB‐1a, Rebif)
Number of subjects: 334
Study: 22297841

Group type: EXPERIMENTAL
Intervention: OPTI-FREE PureMoist (regimen 1)
Number of subjects: 573

Group type: COMPARATOR
Intervention: renu fresh (regimen 2)
Number of subjects: 573
Study: 20652232

Group type: EXPERIMENTAL
Intervention: Epoetin alpha administration
Number of subjects: 214

Group type: COMPARATOR
Intervention: Ribavirin reduction only
Number of subjects: 214
Study: 17650312

Group type: EXPERIMENTAL
Intervention: Remission criteria based on PANSS items (scores < or = 3 for at least six months)
Number of subjects: 675

Group type: COMPARATOR
Intervention: Total PANSS score >60
Number of subjects: 675

Group type: COMPARATOR
Intervention: Total PANSS score <60
Number of subjects: 675
Study: 16059836

Group type: EXPERIMENTAL
Intervention: Indicators of Reha Status (IRES, Version 2) questionnaire
Number of subjects: 8600
Study: 12145002

Group type: EXPERIMENTAL
Intervention: 3 g EPA/d (n = 12)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 3 g DHA/d (n = 12)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (EPA and DHA)
Number of subjects: 38
Study: 9927526

Group type: EXPERIMENTAL
Intervention: Phoneme Manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal Ability
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonverbal Ability
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phonological Memory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rhyme
Number of subjects: 0
Study: 7564352

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 88
Study: 2300545

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (6 g prior to phenylpropanolamine and 3 g every 4 hr for 16 hr)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 4
Study: 7023394

Group type: EXPERIMENTAL
Intervention: Splenorrhaphy
Number of subjects: 105

Group type: COMPARATOR
Intervention: No drainage (Group I)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Closed drainage with Jackson-Pratt drains (Group II)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Open drainage with Penrose drains (Group III)
Number of subjects: 105
Study: 30785660

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 11119

Group type: EXPERIMENTAL
Intervention: Omega-3
Number of subjects: 11119

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 11119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11119
Study: 29981573

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (proparacaine eye drop)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 30
Study: 27012727

Group type: EXPERIMENTAL
Intervention: Hydrated with hand cooling on both hands (HY+2HC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Hydrated with passive rest (HY)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dehydrated with hand cooling on both hands (DY+2HC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Dehydrated with passive rest (DY)
Number of subjects: 9
Study: 25028379

Group type: EXPERIMENTAL
Intervention: Rilonacept 160 mg
Number of subjects: 1315

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1315
Study: 22801933

Group type: EXPERIMENTAL
Intervention: Micronutrient Sprinkles alongside IYCF education
Number of subjects: 1350

Group type: COMPARATOR
Intervention: IYCF education alone
Number of subjects: 1350
Study: 20827168

Group type: EXPERIMENTAL
Intervention: Abacavir/Lamivudine (ABC/3TC)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Tenofovir/Emtricitabine (TDF/FTC)
Number of subjects: 357
Study: 17675142

Group type: EXPERIMENTAL
Intervention: Cisplatin/Paclitaxel
Number of subjects: 792
Study: 15744511

Group type: EXPERIMENTAL
Intervention: Microscopic thyroidectomy (MT group)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Traditional thyroidectomy (TT group)
Number of subjects: 98
Study: 12154150

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) to left frontal cortex
Number of subjects: 12
Study: 10503164

Group type: EXPERIMENTAL
Intervention: Transforming growth factor beta (TGFb) levels in CP patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Serum patterns of N-terminal peptide of type III procollagen (PIIIP) and laminin in CP patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Correlation of TGFb with PIIIP in CP patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Correlation of TGFb with fasting serum glucose levels in CP patients
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Correlation of laminin with PABA test results in CP patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison of PIIIP and laminin levels in LC patients
Number of subjects: 23

Group type: COMPARATOR
Intervention: Inverse correlation between PIIIP and TGFb in LC patients
Number of subjects: 23
Study: 8584551

Group type: COMPARATOR
Intervention: Supine with head of bed flat (Group 1)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Side position with affected extremity straight (Group 2)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Back position with head of bed at 15-30 degrees (Group 3)
Number of subjects: 69
Study: 2497720

Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate (4.0 g omega-3 fatty acids)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate (7.5 g omega-3 fatty acids)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fish-oil treatment (both doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fish-oil treatment (F4 dose)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fish-oil treatment (F7.5 dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Safflower-oil placebo
Number of subjects: 18
Study: 336174

Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine (6-MP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CYC)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Discontinuation of 6-mercaptopurine (6-MP)
Number of subjects: 72
Study: 30855202

Group type: EXPERIMENTAL
Intervention: 3D laparoscopy
Number of subjects: 80

Group type: COMPARATOR
Intervention: 2D laparoscopy
Number of subjects: 80
Study: 29055953

Group type: EXPERIMENTAL
Intervention: Caffeine-based topical liquid 0.2%
Number of subjects: 210

Group type: COMPARATOR
Intervention: Minoxidil 5% solution
Number of subjects: 210
Study: 25051056

Group type: EXPERIMENTAL
Intervention: Combination pill (losartan 50 mg/hydrochlorothiazide 12.5 mg)
Number of subjects: 118

Group type: COMPARATOR
Intervention: ARBs except for losartan
Number of subjects: 118
Study: 22889861

Group type: EXPERIMENTAL
Intervention: Docusate plus sennosides
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo plus sennosides
Number of subjects: 74
Study: 21632967

Group type: EXPERIMENTAL
Intervention: Negative peer feedback
Number of subjects: 185

Group type: COMPARATOR
Intervention: Neutral peer feedback
Number of subjects: 185
Study: 19710262

Group type: EXPERIMENTAL
Intervention: Immediate incubation of blood cultures (intervention arm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (blood cultures not incubated immediately)
Number of subjects: 0
Study: 16776693

Group type: COMPARATOR
Intervention: BoNTA 150 U
Number of subjects: 300

Group type: COMPARATOR
Intervention: BoNTA (various doses)
Number of subjects: 300
Study: 15197290

Group type: EXPERIMENTAL
Intervention: 10-item visual analogue format (10VAF)
Number of subjects: 3122

Group type: COMPARATOR
Intervention: 4-item Chernoff faces
Number of subjects: 3122

Group type: COMPARATOR
Intervention: 5-item Likert format, 5-item satisfaction format, 5-item valuation format
Number of subjects: 3122
Study: 11315660

Group type: EXPERIMENTAL
Intervention: Input-output monitoring test with critical lures from Roediger and McDermott's paradigm
Number of subjects: 0
Study: 10822119

Group type: EXPERIMENTAL
Intervention: Adjudicated study events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjusted interim analysis
Number of subjects: 0
Study: 8878241

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg on Day 1, followed by 5 mg/kg once daily for 4 days)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (40 mg/kg/day in three divided doses for 10 days)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 169

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate
Number of subjects: 169
Study: 2071958

Group type: EXPERIMENTAL
Intervention: Cefuzonam (CZON)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Cefotiam (CTM)
Number of subjects: 145
Study: 6301110

Group type: EXPERIMENTAL
Intervention: Chemo-/radiotherapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Radio-/chemotherapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Symptomatic therapy or combined palliative chemotherapy
Number of subjects: 52
Study: 31950924

Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin/10 mg solifenacin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 50 mg mirabegron
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral hydration for six weeks
Number of subjects: 120
Study: 30328058

Group type: EXPERIMENTAL
Intervention: Quercetin Phytosome (new formulation based on food-grade lecithin)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Unformulated quercetin
Number of subjects: 12
Study: 30278517

Group type: EXPERIMENTAL
Intervention: Nicotine Patch (NP)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Smoking Deprivation (SD)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Smoking (S)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Smoking Deprivation combined with Placebo Patch (SD+PP)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Smoking Deprivation combined with Nicotine Patch (SD+NP)
Number of subjects: 5
Study: 26709597

Group type: EXPERIMENTAL
Intervention: 0.5% benvitimod cream
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1.0% benvitimod cream
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1.5% benvitimod cream
Number of subjects: 36

Group type: COMPARATOR
Intervention: 0% (placebo) benvitimod cream
Number of subjects: 36
Study: 24901635

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 208

Group type: COMPARATOR
Intervention: T-piece
Number of subjects: 208
Study: 21518375

Group type: COMPARATOR
Intervention: Risperidone 2mg alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Risperidone 2mg with ketoconazole 200mg
Number of subjects: 10
Study: 19284399

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg daily)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 95
Study: 17724151

Group type: EXPERIMENTAL
Intervention: Cold‐adapted influenza vaccine, trivalent (CAIV‐T)
Number of subjects: 942

Group type: COMPARATOR
Intervention: Frozen live attenuated influenza vaccine (LAIV)
Number of subjects: 942